Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sage Therapeutic Com (SAGE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sage Therapeutic Com 215 FIRST STREET CAMBRIDGE MA 02142 USA

www.sagerx.com P: 617-299-8380 F: 617-299-8379

Description:

SAGE Therapeutics Inc. is a biopharmaceutical company developing and commercializing medicines to treat life-threatening central nervous system (CNS) disorders. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions. Its initial product candidates include SAGE-547, SAGE-689 and SAGE-217. SAGE Therapeutics, Inc. is based in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 6,487,132
Shares Outstanding, K 41,050
Annual Sales, $ 0 K
Annual Net Income, $ -158,990 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -73,720 K
36-Month Beta 3.03
% of Insider Shareholders 6.10%
% of Institutional Shareholders 95.40%

Growth:

1-Year Total Return 231.33%
3-Year Total Return 303.88%
5-Year Total Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.97 on 11/02/17
Next Earnings Date N/A
Earnings Per Share ttm -6.87
EPS Growth vs. Prev Qtr -4.79%
EPS Growth vs. Prev Year -71.30%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

SAGE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -21.89
Price/Earnings to Growth N/A
Return on Equity % -89.46
Return on Assets % -78.94
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 29.50
Book Value/Share 5.36
Interest Coverage 0.00
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.